HPV Cancer Resources

Helpful Information for Parents, Patients, Partners, and Providers

Helpful Information for Parents, Patients, Partners, and Providers

Stacks Image 56
 

Epidemiology of HPV Cancers

  • How prevalent are genital HPV infections in the US among different racial and ethnic groups?

    Open or Close
    According to the CDC:

    During 2013–2014, prevalence of any genital HPV was 42.5% among adults aged 18–59, 45.2% among men and 39.9% among women.

    Overall, and for both men and women, prevalence of any genital HPV was lowest among non-Hispanic Asian adults and highest among non-Hispanic black adults, with no significant difference in prevalence between non-Hispanic white and Hispanic adults.
    Prevalence of any genital HPV was higher among men than women overall and among non-Hispanic white adults. The pattern was similar for Hispanic adults, but the difference between men and women was not statistically significant.

    Prevalence of high-risk genital HPV was lowest among non-Hispanic Asian adults and highest among non-Hispanic black adults.

    During 2013–2014, the prevalence of high-risk HPV was 22.7% among adults aged 18–59, 25.1% among men and 20.4% among women.

    Overall, and for both men and women, prevalence of high-risk genital HPV was lowest among non-Hispanic Asian adults and highest among non-Hispanic black adults, with no significant difference in prevalence between non-Hispanic white and Hispanic adults.

    Prevalence of any genital HPV was higher among men than women overall and among non-Hispanic white and non-Hispanic black adults.”
  • How prevalent are oral HPV infections in the US?

    Open or Close
    According to the CDC:

    “During 2011–2014, prevalence of any oral HPV was 7.3% among adults aged 18–69, 11.5% among men and 3.3% among women

    Prevalence of any oral HPV was lower among non-Hispanic Asian adults (2.9%) and higher among non-Hispanic black adults (9.7%) compared with both non-Hispanic white (7.3%) and Hispanic adults (7.0%). For men, there was a similar racial and ethnic pattern.

    Prevalence of any oral HPV was lowest among non-Hispanic Asian women. No significant difference in prevalence was seen among non-Hispanic white, non-Hispanic black, and Hispanic women.

    Men had a higher prevalence of oral HPV than women, overall and within each race and Hispanic group.

    Prevalence of high-risk oral HPV was lower among non-Hispanic Asian adults compared with other race and Hispanic groups:

    During 2011–2014, prevalence of high-risk oral HPV was 4.0% among adults aged 18–69, 6.8% among men and 1.2% among women.

    Prevalence was lower among non-Hispanic Asian adults, overall (1.7%) and among men (2.3%), than non-Hispanic white (4.2% all, 7.3% men), non-Hispanic black (4.3% all, 7.5% men), and Hispanic (3.4% all, 5.4% men) adults.

    No differences were seen in prevalence of high-risk oral HPV by race and Hispanic group among women (1.1%–1.7%).

    Prevalence of high-risk oral HPV was higher among men than women in all race and Hispanic groups, although the difference was not significant among non-Hispanic Asian adults.”
  • I hear that the incidence of HPV-caused oral cancers is soaring in men. What are the facts?

    Open or Close
    Stacks Image 62

    Hokusai’s The Great Wave (Re-interpreted by Josh and Stewart Lyman)

    This is true. In the US, the number of yearly cases of HPV-caused oropharyngeal tumors has more than doubled between 1999 and 2015. It went from 6,996 cases in 1999 to 15,479 cases in 2015 (an increase of 121 percent).

    According to the CDC, in 2015, oropharyngeal cancers made up 82% of all HPV-cancers in men, followed by anal cancers (12%) and penile cancers (6%).

    The percentage of oropharyngeal cancers that were HPV positive increased from 16.3% in the period 1984–1989 to over 70% in 2000–2004 in the United States. This increase is highest among middle-aged white men (40 to 59 years old). Reference: Pytynia KB et al Epidemiology of HPV-associated oropharyngeal cancer Oral Oncol. 2014 May ; 50(5): 380–386. doi:10.1016/j.oraloncology.2013.12.019.

    In oropharyngeal cancers, HPV 16 is the most common high-risk infection. HPV 16 accounts for 90% of HPV-related OPCs. Reference: Guo T et al The Potential Impact of Prophylactic HPV Vaccination on Oropharynx Cancer. Cancer. 2016 August 1; 122(15): 2313–2323. doi:10.1002/cncr.29992.

    This topic has been widely covered in the popular press: e.g. Oral HPV More Common in Men Than Women NY Times 2012

    Here are 5 recent papers focused on this issue:
    HPV Related Disease Burden and Impact of HPV Vaccine (2018) by Martin Mahoney, MD, PhD Roswell Park Cancer Institute

    Oropharyngeal Cancer Epidemiology by Kristina R. Dahlstrom, Ph.D. MD Anderson Cancer Center

    Oropharyngeal Cancer: Clinical Implications of the HPV Epidemic by Erich M. Sturgis, M.D., M.P.H.

    Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study Mourad et al J Oral Maxillofac Surg 75:2562-2572, 2017

    Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States Chaturvedi et al J Clin Oncol. 2011 Nov 10; 29(32): 4294–4301

    Prevalence of Oral HPV Infection in the United States, 2009-2010 by Gillison et al JAMA. 2012;307(7):693-703

    This is not only happening in the US. Here’s a report of a similar phenomenon in Sweden:
    Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral‐induced carcinoma?
  • Has there also been a big spike in HPV-caused oropharyngeal cancers in women?

    Open or Close
    Not really. The number or women with HPV-caused oropharyngeal cancers climbed from 2,409 in 1999 to 3,438 in 2015 (a 40 percent increase). The ratio of male:female HPV-caused oropharyngeal cancers was 2.9 to 1 in 1999, but climbed to 4.5 fold by 2015. The incidence of these cancers is growing much faster in men than women, and is thought to follow increases in oral HPV infections in men.

    According to the CDC, in 2015, oropharyngeal cancers made up only 14% of all HPV-cancers in women. The most prevalent HPV-cancer in women is cervical cancer (48%), followed by anal cancers (18%), vulval cancers (16%), and vaginal cancers (3%). Contrast this with men, where oropharyngeal cancers made up 82% of all HPV-cancers in men, followed by anal cancers (12%) and penile cancers (6%).

  • How are HPV strains shared between people?

    Open or Close
    According to the CDC:
    HPV is primarily spread by intimate skin to skin contact. You can be exposed to the virus by having oral, vaginal, or anal sexual contact with someone who is already infected. The virus can be transmitted by penetrative as well as non-penetrative sexual contact (genital-genital, oral-genital, anal-genital, oral-anal). The hands can also transmit a genital, oral, or anal infection. Since many people have no symptoms of infection, it’s pretty common to become infected and to not even realized that has happened.

    Most people will never develop symptoms of the infection as their immune systems will successfully eliminate the virus. However, some infected individuals will go on to develop either genital or anal warts, or to develop oral, anal, vaginal, vulval, penile, or cervical cancers. It can take years or even decades for these cancers to develop, making it very difficult to identify when a person actually became infected. Risk factors for catching HPV infections include an early age of first sexual intercourse, an increasing number of sexual partners, smoking, and having a compromised immune system.

    Risk factors for catching HPV infections include:

    Number of sexual partners. The more sexual partners you have, the more likely you are to contract a genital HPV infection. Having sex with a partner who has had multiple sex partners also increases your risk.
    Age. Common warts occur mostly in children. Genital warts occur most often in adolescents and young adults.
    Weakened immune systems. People who have weakened immune systems are at greater risk of HPV infections. Immune systems can be weakened by HIV/AIDS or by immune system-suppressing drugs used after organ transplants.
    Damaged skin. Areas of skin that have been punctured or opened are more prone to develop common warts.
    Personal contact. Touching someone's warts or not wearing protection before contacting surfaces that have been exposed to HPV — such as public showers or swimming pools — might increase your risk of HPV infection.

    Source: Mayo Clinic

    Risk factors specific for oral HPV infections include:
    Oral sex. The prevalence of oral HPV infection was increased in subjects who had experience with oral sex as compared to those who did not.
    Number of oral sex partners. Those with more oral sex partners had a higher incidence rate for HPV infection.
    Smoking. This was significantly associated with oral HPV infections in both men and women

    Source: See Shigeshi and Sugiyama Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis J Clin Med Res. 2016 Oct; 8(10): 721–729. doi: 10.14740/jocmr2545w
  • How does the CDC define “high risk” strains of HPV (and related terms)?

    Open or Close
    Any oral HPV: Oral rinse sample tested positive to one or more of the 37 HPV types listed under “All HPV types.”

    High-risk oral HPV: Oral rinse sample tested positive to one or more of 14 high-risk HPV types (see definition) out of the 37 HPV types.

    Any genital HPV in women: Vaginal swab sample tested positive to one or more of the 37 HPV types listed under “All HPV types.”

    High-risk genital HPV in women: Vaginal swab sample tested positive to one or more of the 14 high-risk HPV types (see definition) out of the 37 HPV types.

    Any genital HPV in men: Penile swab sample tested positive to one or more of the 37 HPV types listed under “All HPV types.”

    High-risk genital HPV in men: Penile swab sample tested positive to one or more of the 14 high-risk HPV types (see definition) out of the 37 HPV types.

    All HPV types (includes types detected by L1 consensus polymerase chain reaction): 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, 89, or IS39.

    High-risk HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, or 68.

    Source: CDC Prevalence of HPV in Adults Aged 18–69: United States, 2011–2014
  • What percentage of women in the US have cervical HPV infections?

    Open or Close
    The prevalence of any cervical HPV infection is 26.8% for ages 14-59. 15.2% of women have are infected with high-risk (e.g. potentially cancer causing) strains of HPV, the most common being HPV16. The peak prevalence of cervical HPV infection is 44.8% in women ages 20-24, a few years following their sexual debut.
    Reference: Guo T et al The Potential Impact of Prophylactic HPV Vaccination on Oropharynx Cancer. Cancer. 2016 August 1; 122(15): 2313–2323. doi:10.1002/cncr.29992.
  • Why is the incidence of oral HPV infections bi-modal with respect to age, with peaks at 30 to 34 and 60 to 64?

    Open or Close
    To visualize this bimodal peak in HPV infection, see Fig. 4 in Gillison ML et al Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma J. Clin. Oncol. 33, #29, 3235-3242 DOI: 10.1200/JCO.2015.61.6995

    According to Guo T et al The Potential Impact of Prophylactic HPV Vaccination on Oropharynx Cancer Cancer. 2016 August 1; 122(15): 2313–2323. doi:10.1002/cncr.29992., “Explanations for the first peak include a surge in oral HPV infection after sexual debut and at peak sexual activity. The second peak may be attributed to potential reactivation of dormant infections with immunosenescence, increased HPV exposure in divorced or widowed populations, and/or increased rates of persistent infection which increase overall prevalence.

    These are interesting hypotheses, but I don’t know of any data that really supports one idea over another regarding the second peak at age 60 to 64. I think it remains unexplained exactly why there are fewer cases of oropharyngeal cancer in those in the 35-59 year old age group. This may be a difficult question to answer epidemiologically.
  • Can the HPV virus that’s infected one area of your body migrate to another part?

    Open or Close
    The answer to this question is maybe, but exactly how easily this occurs is unclear. The best evidence for this is the fact that survivors of HPV cancers are at a slightly increased risk of developing a second HPV-caused cancer (SEE BELOW). This could indicate that the virus has spread in the body, but it could also mean that the person is infected with two different cancer-causing strains of HPV, and those infections just happen to be in separate places. The only way to really answer this question is to do genetic sequencing of the virus from different body sites, and see if the exact same sequence is found at multiple sites. Even then, this would not guarantee that the virus has spread, because the person could have been infected at multiple locations during the initial infection.
  • Is the relative prevalence of different HPV strains found in cervical cancer similar around the world ?

    Open or Close
    No. While HPV 16 is the predominant strain in all countries where these studies have been done, the percentage of other strains differs markedly. HPV was found in 99.7 percent of cervical cancer samples analyzed worldwide. See Waldboomers et al Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19, 1999.
  • Do the partners of those diagnosed with HPV+ oral cancers have a higher incidence of oral infection with a cancer-causing strain of HPV than the general population?

    Open or Close
    No. HPV status was looked at in the female and male partners of men who had HPV+ oral cancers. The researchers found that the partners had comparable oncogenic oral HPV prevalence (i.e. they were HPV 16+) compared with members of the general population of the same age (1.2% v 1.3%). No precancers or cancers were identified during partner oral cancer screening examinations either.

    Reference: D’Souza et al Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. J Clin Oncol. 10, 2408-15, 2014. doi: 10.1200/JCO.2014.55.1341.
  • Are survivors of HPV-assocated cancers at increased risk of developing a second HPV-associated cancer compared to the general population?

    Open or Close
    Unfortunately, yes. Survivors of HPV-associated cancers are at an increased risk of developing HPV second primary cancers (HPV-SPCs). Among both women and men, the risk of developing HPC-SPC at the original cancer site was higher than that of developing HPC-SPC at a different cancer site. Among women with index vaginal, vulvar, and anal cancers, the risk for all HPV-SPCs remained high. The HPV-SPC risk was lowest among women with index cervical cancer. Among men, the oropharyngeal SPC risk was elevated after index penile and anal cancers. Given the large difference in the HPV-SPC risk between survivors of HPV-associated cancers and that of non–HPV-associated cancers, it is likely that persistent HPV infection contributes to the development of HPV-SPCs among survivors of HPV-associated cancers.

    Reference: Suk et al Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus–Associated Cancers. JAMA Network Open. 2018;1(5):e181999. doi:10.1001/jamanetworkopen.2018.1999 (FREE ARTICLE)